Indications and uses
Homeopathic cream used for reducing the severity and frequency of insect bites.
MOZI-Q
- Manufacturer
- Xerion Dispensary Ltd. | Les Importations Herbasante Inc.
- Effective date
- 2023-12-17
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 5
- Source
- full-release
- Hydrated at
- 2026-06-01 02:25:02
Label at a glance#
ProductMOZI-Q
Active ingredientLEDUM PALUSTRE TWIG, URTICA URENS, GRINDELIA HIRSUTULA FLOWERING TOP, SIMABA CEDRON SEED, DELPHINIUM STAPHISAGRIA SEED
Label structure9 sections
Dosage and administration
Adults, children,and infants: apply a small amount to exposed skin or affected areas, Repeat every 2-3 hours as needed. for external use only. Consult a health care practitioner if symptoms persist or worsen.
Contacts and useful links#
Websitewww.mozi-q.com
www.Mozi-Q.com
www.Mozi-Q.comLabel contents#
Full prescribing information#
Drug Facts Active Ingredients
Wild Rosemary (Ledum palustre (leafy twigs)) 3 X
Dwarf Nettle (Urtica urens (whole plant)) 6 X
Grindelia (Grindelia (aerial part)) 6 C
Cedron (Cedron (seed)) 4 C
Stavesacre (Staphysagria (seeds)) 4 X
Purpose
Aids in healing insect bites
Alleviates skin inflammation or itchiness
Speeds up healing in the skin following physical irritation
Relieves itch from insect stings and bites
Keep out of reach of children
Keep out of reach of children.
Uses
Homeopathic cream used for reducing the severity and frequency of insect bites.
Warnings
- Stop use and ask a doctor if symptoms persist or worsen
- If pregnant or breast-feeding, ask a health professional before use.
- In case of overdose, get medical help or contact a Poison Control Center immediately.
Directions
Adults, children,and infants: apply a small amount to exposed skin or affected areas, Repeat every 2-3 hours as needed. for external use only. Consult a health care practitioner if symptoms persist or worsen.
Other Information
- Blister packs and packaging have been tampered sealed for your protection
- Protect from excessive moisture
- Minimize contact with electronic devices
Inactive Ingredients
Aqua, Butyl 4-ketovalerate, Butyrospermum Parkii (Shea) Oil, Caprylic/Capric triglycerides, Ceteareth-12, Cetostearyl Alcohol, Dicaprylyl Ether, Glycerol, Glyceryl distearate, Glyceryl monopalmitate, Linoleic Acid, Potassium Sorbate, Pyridoxine Hydrochloride, Tocopherols concentrate mixed (high alpha type), Triethanolamine, Xanthan Gum
Product label
MOZI-Q
Body Lotion
Homeopathic cream used for the reducing the severity and frequency of insect bites.
50g
Questions or Comments?
For further information or serious adverse reporting
By Phone 1-877-XERION-1 (1-877-937-4661)
By Mail 40 East Main St. #953 Newark, DE 19711
Manufactured for and Distributed by
Xerion Dispensary Ltd.
40 East Main St. #953
Newark, DE 19711
Made in Canada
BLISTER PACKS AND PACKAGING HAVE BEEN TAMPERED SEALED FOR YOUR PROTECION
UPC
LOT No
EXP DATE
NDC 0000000000000
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 59361619-24d9-b610-eca6-5a7f25ed5e03 | Product name | 5 | 20240909 |
| 5e18e798-5614-cf5c-0185-38b1cb77a093 | Product name | 2 | 20160822 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 53590-104-01 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-8ec0-d83d-e063-dadaa90ab31f | fdbe3c12-861e-459f-a16a-219084a79b42 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 53590-104-01 | MOZI-Q | 50 g in 1 TUBE | LOTION | 50 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 53590-104 | MOZI-Q (LEDUM PALUSTRE TWIG, URTICA URENS, SIMABA CEDRON SEED, DELPHINIUM STAPHISAGRIA SEED, GRINDELIA HIRSUTULA FLOWERING TOP) LOTION [XERION DISPENSARY LTD.] | 5 | Legacy NDC, 1 package rows | 20231218_fdbe3c12-861e-459f-a16a-219084a79b42.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| DELPHINIUM STAPHISAGRIA SEED | ACTIVE INGREDIENT | 00543AP1JV | 1 | |
| GRINDELIA HIRSUTULA FLOWERING TOP | ACTIVE INGREDIENT | IDB0NAZ6AI | 1 | |
| LEDUM PALUSTRE TWIG | ACTIVE INGREDIENT | 877L01IZ0P | 1 | |
| SIMABA CEDRON SEED | ACTIVE INGREDIENT | KHI40967MV | 1 | |
| URTICA URENS | ACTIVE INGREDIENT | IHN2NQ5OF9 | 1 | |
| DELPHINIUM STAPHISAGRIA SEED | ACTIVE MOIETY | 00543AP1JV | 1 | |
| GRINDELIA HIRSUTULA FLOWERING TOP | ACTIVE MOIETY | IDB0NAZ6AI | 1 | |
| LEDUM PALUSTRE TWIG | ACTIVE MOIETY | 877L01IZ0P | 1 | |
| SIMABA CEDRON SEED | ACTIVE MOIETY | KHI40967MV | 1 | |
| URTICA URENS | ACTIVE MOIETY | IHN2NQ5OF9 | 1 | |
| BUTYL LEVULINATE | INACTIVE INGREDIENT | OI56208RTB | 1 | |
| CETEARETH-12 | INACTIVE INGREDIENT | 7V4MR24V5P | 1 | |
| CETOSTEARYL ALCOHOL | INACTIVE INGREDIENT | 2DMT128M1S | 1 | |
| DICAPRYLYL ETHER | INACTIVE INGREDIENT | 77JZM5516Z | 1 | |
| DIMETHICONE | INACTIVE INGREDIENT | 92RU3N3Y1O | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| GLYCERYL DISTEARATE | INACTIVE INGREDIENT | 73071MW2KM | 1 | |
| GLYCERYL PALMITATE | INACTIVE INGREDIENT | 6Y2XJ05B35 | 1 | |
| LINOLEIC ACID | INACTIVE INGREDIENT | 9KJL21T0QJ | 1 | |
| MEDIUM-CHAIN TRIGLYCERIDES | INACTIVE INGREDIENT | C9H2L21V7U | 1 | |
| POTASSIUM SORBATE | INACTIVE INGREDIENT | 1VPU26JZZ4 | 1 | |
| PYRIDOXINE HYDROCHLORIDE | INACTIVE INGREDIENT | 68Y4CF58BV | 1 | |
| SHEANUT OIL | INACTIVE INGREDIENT | O88E196QRF | 1 | |
| TOCOPHEROL | INACTIVE INGREDIENT | R0ZB2556P8 | 1 | |
| TROLAMINE | INACTIVE INGREDIENT | 9O3K93S3TK | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 | |
| XANTHAN GUM | INACTIVE INGREDIENT | TTV12P4NEE | 1 |
Products#
Every source-derived product name is available through these pages.
- MOZI-Q
- Ledum Palustre Twig, Urtica Urens, Simaba Cedron Seed, Delphinium Staphisagria Seed, Grindelia Hirsutula Flowering Top
- LEDUM PALUSTRE TWIG
- URTICA URENS
- GRINDELIA HIRSUTULA FLOWERING TOP
- SIMABA CEDRON SEED
- DELPHINIUM STAPHISAGRIA SEED
- WATER
- BUTYL LEVULINATE
- SHEANUT OIL
- MEDIUM-CHAIN TRIGLYCERIDES
- CETEARETH-12
- CETOSTEARYL ALCOHOL
- DICAPRYLYL ETHER
- DIMETHICONE
- GLYCERIN
- GLYCERYL DISTEARATE
- GLYCERYL PALMITATE
- LINOLEIC ACID
- POTASSIUM SORBATE
- PYRIDOXINE HYDROCHLORIDE
- TOCOPHEROL
- TROLAMINE
- XANTHAN GUM
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 53590-104 | 53590-104-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / ORAL | 26208 mg | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | GEL, METERED / TRANSDERMAL | 14 mg | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | SOLUTION / NASAL | NA | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | TABLET, ORALLY DISINTEGRATING / ORAL | 0.15 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / NASAL | 10 mg/1ml | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | SPRAY / TOPICAL | 540 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | TABLET / ORAL | 56 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / OPHTHALMIC | 0.88 %w/w | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | SUSPENSION / RECTAL | 452 mg | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | INJECTION, SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | 990.3 mg | ||
| GLYCERYL PALMITATE | GLYCERYL PALMITATE | 6Y2XJ05B35 | LOTION / TOPICAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / RESPIRATORY (INHALATION) | 5 %w/w | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | SPRAY, METERED / SUBLINGUAL | 110 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / ORAL | 300 mg/1ml | ||
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | SPRAY / TOPICAL | 1 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / VAGINAL | 227.9 mg | ||
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | SUPPOSITORY / VAGINAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / VAGINAL | 60 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / TOPICAL | 1971 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | SOLUTION, GEL FORMING, EXTENDED RELEASE / OPHTHALMIC | 0.6 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SUSPENSION / SUBCUTANEOUS | 1.6 %w/v | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | SOLUTION / ORAL | 84 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | LOZENGE / ORAL | 1264 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, EMULSION / INTRAVENOUS | 24100 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DOUCHE / VAGINAL | 1 %w/w | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | TROCHE / ORAL | 948 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | SUSPENSION, EXTENDED RELEASE / ORAL | 186.8 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE, DENTIFRICE / DENTAL | 18 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TOPICAL | 500 mg | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | LIQUID / TOPICAL | NA | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | SUSPENSION/ DROPS / ORAL | 22 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | AEROSOL, FOAM / TOPICAL | 0.27 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / DENTAL | 15 %w/v | ||
| TOCOPHEROL | TOCOPHEROL | R0ZB2556P8 | TABLET / ORAL | 0.08 mg | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | TABLET / ORAL | 2 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION, CONCENTRATE / ORAL | 200 mg/1ml | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | EMULSION / OPHTHALMIC | 0.47 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPRAY / NASAL | 22.3 mg/1ml | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | CREAM / TOPICAL | 0.25 %w/w | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | GEL / TOPICAL | 6 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | AEROSOL, FOAM / TOPICAL | 21 mg | ||
| TOCOPHEROL | TOCOPHEROL | R0ZB2556P8 | INJECTION, EMULSION / INTRAVENOUS | 0.02 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / TOPICAL | 1720 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET / ORAL | 42 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 36 mg | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | POWDER, FOR SUSPENSION / ORAL | 3390 mg/5ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | EMULSION / INTRAVENOUS | 2.2 %w/v | ||
| MEDIUM-CHAIN TRIGLYCERIDES | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | TABLET, ORALLY DISINTEGRATING / ORAL | 1 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | GRANULE, FOR SUSPENSION / ORAL | 450 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | SOLUTION / OPHTHALMIC | 0.6 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / ORAL | 2400 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / ORAL | 32400 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | FILM, SOLUBLE / ORAL | 1 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYRUP / ORAL | 16734 mg | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | AEROSOL, METERED / RECTAL | ADJ PH | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPONGE / TOPICAL | 2 %w/w | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | GRANULE, FOR SUSPENSION / ORAL | 80 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 6 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, COATED / ORAL | 14.21 mg | ||
| TROLAMINE | TROLAMINE | 9O3K93S3TK | CREAM, AUGMENTED / TOPICAL | 20 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 65b26bf9-ccc0-44db-96e4-511975f9c8d4 | fdbe3c12-861e-459f-a16a-219084a79b42 | 2023-12-17 | Warnings | 65b26bf9-ccc0-44db-96e4-511975f9c8d4 fdbe3c12-861e-459f-a16a-219084a79b42 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.